Logo image of SNBR

SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SNBR - US83125X1037 - Common Stock

8.59 USD
+0.69 (+8.73%)
Last: 1/12/2026, 5:24:04 PM
8.59 USD
0 (0%)
After Hours: 1/12/2026, 5:24:04 PM
Fundamental Rating

1

Overall SNBR gets a fundamental rating of 1 out of 10. We evaluated SNBR against 122 industry peers in the Specialty Retail industry. SNBR has a bad profitability rating. Also its financial health evaluation is rather negative. SNBR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SNBR had negative earnings in the past year.
In the past year SNBR has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.
Of the past 5 years SNBR 4 years had a positive operating cash flow.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -10.42%, SNBR is doing worse than 74.59% of the companies in the same industry.
SNBR has a Return On Invested Capital (3.59%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for SNBR is below the industry average of 12.24%.
The last Return On Invested Capital (3.59%) for SNBR is well below the 3 year average (7.69%), which needs to be investigated, but indicates that SNBR had better years and this may not be a problem.
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROIC 3.59%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

SNBR has a Operating Margin of 1.35%. This is comparable to the rest of the industry: SNBR outperforms 45.08% of its industry peers.
In the last couple of years the Operating Margin of SNBR has declined.
SNBR has a Gross Margin of 60.05%. This is amongst the best in the industry. SNBR outperforms 88.52% of its industry peers.
SNBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 60.05%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SNBR is destroying value.
Compared to 1 year ago, SNBR has more shares outstanding
SNBR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for SNBR is higher compared to a year ago.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -0.11, we must say that SNBR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.11, SNBR is not doing good in the industry: 80.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.11
ROIC/WACC0.4
WACC9%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

SNBR has a Current Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SNBR's Current ratio of 0.19 is on the low side compared to the rest of the industry. SNBR is outperformed by 97.54% of its industry peers.
A Quick Ratio of 0.09 indicates that SNBR may have some problems paying its short term obligations.
With a Quick ratio value of 0.09, SNBR is not doing good in the industry: 95.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.09
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. Growth

3.1 Past

SNBR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.40%.
SNBR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.95%.
The Revenue has been decreasing by -0.19% on average over the past years.
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%

3.2 Future

SNBR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.93% yearly.
SNBR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.38% yearly.
EPS Next Y-326.89%
EPS Next 2Y20.31%
EPS Next 3Y40.55%
EPS Next 5Y34.93%
Revenue Next Year-17%
Revenue Next 2Y-9.86%
Revenue Next 3Y-4.18%
Revenue Next 5Y-3.38%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SNBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNBR is valued cheaply inside the industry as 96.72% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.29
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as SNBR's earnings are expected to grow with 40.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.31%
EPS Next 3Y40.55%

0

5. Dividend

5.1 Amount

SNBR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SLEEP NUMBER CORP

NASDAQ:SNBR (1/12/2026, 5:24:04 PM)

After market: 8.59 0 (0%)

8.59

+0.69 (+8.73%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-03 2026-03-03/amc
Inst Owners89.35%
Inst Owner Change0%
Ins Owners6.63%
Ins Owner Change5.16%
Market Cap195.77M
Revenue(TTM)1.44B
Net Income(TTM)-78.11M
Analysts48.89
Price Target5.61 (-34.69%)
Short Float %31.87%
Short Ratio7.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-915.82%
Min EPS beat(2)-937.57%
Max EPS beat(2)-894.07%
EPS beat(4)1
Avg EPS beat(4)-818.76%
Min EPS beat(4)-1452.29%
Max EPS beat(4)8.9%
EPS beat(8)3
Avg EPS beat(8)-410.77%
EPS beat(12)5
Avg EPS beat(12)-256.42%
EPS beat(16)7
Avg EPS beat(16)-175.27%
Revenue beat(2)0
Avg Revenue beat(2)-8.66%
Min Revenue beat(2)-10.05%
Max Revenue beat(2)-7.26%
Revenue beat(4)0
Avg Revenue beat(4)-6.41%
Min Revenue beat(4)-10.05%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.76%
Revenue beat(12)1
Avg Revenue beat(12)-4.74%
Revenue beat(16)3
Avg Revenue beat(16)-4.59%
PT rev (1m)0%
PT rev (3m)-26.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-303.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-283.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 2.29
EPS(TTM)-3.41
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-2.06
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS63.22
BVpS-22.88
TBVpS-25.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROCE -13.07%
ROIC 3.59%
ROICexc 3.6%
ROICexgc 4.25%
OM 1.35%
PM (TTM) N/A
GM 60.05%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexgc growth 3Y-45.92%
ROICexgc growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score4
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.42
Cap/Depr 31.01%
Cap/Sales 1.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.09
Altman-Z -0.11
F-Score4
WACC9%
ROIC/WACC0.4
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
EPS Next Y-326.89%
EPS Next 2Y20.31%
EPS Next 3Y40.55%
EPS Next 5Y34.93%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%
Revenue Next Year-17%
Revenue Next 2Y-9.86%
Revenue Next 3Y-4.18%
Revenue Next 5Y-3.38%
EBIT growth 1Y-36.2%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year164.29%
EBIT Next 3Y59.7%
EBIT Next 5Y36.4%
FCF growth 1Y38.86%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-136.39%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%

SLEEP NUMBER CORP / SNBR FAQ

What is the fundamental rating for SNBR stock?

ChartMill assigns a fundamental rating of 1 / 10 to SNBR.


What is the valuation status of SLEEP NUMBER CORP (SNBR) stock?

ChartMill assigns a valuation rating of 2 / 10 to SLEEP NUMBER CORP (SNBR). This can be considered as Overvalued.


Can you provide the profitability details for SLEEP NUMBER CORP?

SLEEP NUMBER CORP (SNBR) has a profitability rating of 3 / 10.


What is the expected EPS growth for SLEEP NUMBER CORP (SNBR) stock?

The Earnings per Share (EPS) of SLEEP NUMBER CORP (SNBR) is expected to decline by -326.89% in the next year.